Poolbeg Pharma Balance Sheet Health

Financial Health criteria checks 4/6

Poolbeg Pharma has a total shareholder equity of £16.6M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £17.1M and £511.0K respectively.

Key information

0%

Debt to equity ratio

UK£0

Debt

Interest coverage ration/a
CashUK£14.12m
EquityUK£16.56m
Total liabilitiesUK£511.00k
Total assetsUK£17.07m

Recent financial health updates

Recent updates

We're Hopeful That Poolbeg Pharma (LON:POLB) Will Use Its Cash Wisely

Feb 16
We're Hopeful That Poolbeg Pharma (LON:POLB) Will Use Its Cash Wisely

We're Hopeful That Poolbeg Pharma (LON:POLB) Will Use Its Cash Wisely

Oct 05
We're Hopeful That Poolbeg Pharma (LON:POLB) Will Use Its Cash Wisely

We're Hopeful That Poolbeg Pharma (LON:POLB) Will Use Its Cash Wisely

Jun 01
We're Hopeful That Poolbeg Pharma (LON:POLB) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Poolbeg Pharma's (LON:POLB) Cash Burn Situation

Jul 12
Here's Why We're Not Too Worried About Poolbeg Pharma's (LON:POLB) Cash Burn Situation

Financial Position Analysis

Short Term Liabilities: POLB's short term assets (£14.9M) exceed its short term liabilities (£511.0K).

Long Term Liabilities: POLB has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: POLB is debt free.

Reducing Debt: POLB has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if POLB has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if POLB has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.